Eli Lilly Alzheimer’s treatment donanemab slowed disease progression in clinical trial
Donanemab, a monthly antibody infusion made by pharmaceutical company Eli Lilly, also significantly reduced brain plaque associated with Alzheimer’s disease.
Here’s what to expect from today’s Federal Reserve announcement
Where the intrigue comes in is how the central bank proceeds from here.
FBI says former agent arrested over Jan. 6 called officers Nazis and encouraged mob to ‘kill ’em’
Jared L. Wise, who worked at the FBI for 13 years ending in 2017, was arrested Monday in Oregon.
Starbucks earnings beat as China reverses same-store sales declines
Starbucks said its same-store sales climbed 11% in its fiscal second quarter.
Gilead Sciences battles U.S. government in court over HIV prevention patent
The U.S. claims Gilead’s drugs Truvada and Descovy infringe on CDC patents.
Lawmakers update Kids Online Safety Act to address potential harms, but fail to appease some activists, industry groups
As Congress and President Joe Biden have made clear kids online protections are a key priority, KOSA has become one of the leading bills on the subject.
New York and California lost over $90 billion in income to low-tax states during Covid
The losses accelerated the trend of high-earners relocating to lower-tax states like Florida and Texas.
Buy these cheap, defensive stocks as long as recession fears keep mounting, UBS says
UBS tells investors to stick to dependable defensives, given recent softness in economic numbers.
New York poised to pass first statewide law banning natural gas in new buildings
The law banning fossil fuel combustion would likely take effect in 2026 for most new buildings under seven stories and in 2029 for larger buildings.
Ford posts stellar first quarter, boosted by fleet and legacy truck divisions
Ford is reporting its quarterly financial results by business unit, instead of by region, for the first time.
